Infection-Fighting stitches tested for C-Sections, but trial stopped early
NCT ID NCT03386240
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether using stitches coated with an antibacterial agent (triclosan) could reduce infections after cesarean delivery. Over 1,100 women were planned to take part, but the trial was stopped early. Because it was terminated, we cannot draw firm conclusions about whether these special stitches help prevent infections after C-sections.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Triclosan-coated sutures (Vicryl-plus, Monocryl-plus, PDS-plus)
- What this could lead to
- If it had worked, this could have pointed toward a simple way to prevent wound infections after cesarean delivery.
- What could go wrong
- The trial was terminated early, so we don't have clear evidence that these sutures work for cesarean infections. The results are inconclusive.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
1,169 people
The number who actually took part.
- Started
-
Jan 2018
- Finished
-
Nov 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18-50 years of age. * Women ≥ 24 weeks' viable gestation. * To undergo cesarean delivery. Exclusion Criteria: * Patient unwilling or unable to provide consent. * No prenatal care or a non-resident patient who is unlikely to be followed-up after delivery. * Immunosuppressed patients: i.e., taking systemic immunosuppressant or steroids (e.g. transplant patients; not including steroids for lung maturity), HIV with CD4\<200, or other. * Decision to use other than suture closure (e.g. secondary wound closure, mesh closure). * Skin infection. * Coagulopathy. * High likelihood of additional surgical procedure beyond cesarean (e.g. scheduled hysterectomy, bowel or adnexal surgery). * Allergy to Triclosan. * Incarcerated individuals.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cesarean section complications are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Texas Medical Branch in Galveston
Galveston, Texas, 77550, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A single class may help new mothers avoid Long-Term pain after C-Section
- Can a simple ointment make surgical scars heal better?
- Could a 20% lower anesthetic dose make C-Sections safer?
- Which wound closure cuts infection risk after abdominal surgery?
- Can a single dose extend Post-Cesarean pain relief?
- A new wash could outsmart spine surgery infections without the seroma risk